Acquired epidermodysplasia verruciformis in a child with the human immunodeficiency virus

Pediatric Dermatology

Volumn 30, Issue 6, 2013, Pages

  Cowan, Katelyn R ^a   Gonzalez Santiago, Tania M ^a   Tollefson, Megha M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; RETINOIC ACID;

ACANTHOSIS; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CHILD; CHILDHOOD DISEASE; EPIDERMODYSPLASIA VERRUCIFORMIS; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOPIGMENTATION; KERATINOCYTE; MALE; PALLOR; PAPULE; PRIORITY JOURNAL; SCHOOL CHILD; SKIN EXAMINATION; STAINING; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIOPSY; CHILD; DIAGNOSIS, DIFFERENTIAL; EPIDERMODYSPLASIA VERRUCIFORMIS; HIV INFECTIONS; HUMANS; INFANT, NEWBORN;

EID: 84887627756     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12164     Document Type: Article

References (5)

1. Lewandowsky F, Lutz W,. A case of a previously undescribed skin disease (epidermodysplasia verruciformis) [in German]. Arch Dermatol Syph 1922; 141: 193-203.
2. Berger TG, Sawchuk WS, Leonardi C, et al. Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease. Br J Dermatol 1991; 124: 79-83.
3. Moore RL, de Schaetzen V, Joseph M, et al. Acquired epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterization. Arch Dermatol 2012; 148: 128-130.
4. Nuovo GJ, Ishag M,. The histologic spectrum of epidermodysplasia verruciformis. Am J Surg Pathol 2000; 24: 1400-1406.
5. Morrison C, Eliezri Y, Magro C, et al. The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients. J Cutan Pathol 2002; 29: 480-489.